Atlas Trials

Study of the Impact of Everolimus Treatment on Lymphocytes NK (Natural Killer) Development and Functions for Patients With a Metastatic Breast Cancer (HR+ / HER2/Neu Negative)

Clinical trial NCT02536625 · COMPLETED

Trial details

NCT number
NCT02536625
Sponsor
Centre Leon Berard
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2015-10-01
Primary completion
2019-04-01
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.